Not cancer · Austria
Fatty liver disease (MASLD/MASH)
How is it diagnosed today? It is usually found after blood tests or scans done for another reason show signs of problems with your liver. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.6 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Weight loss, healthy diet and exercise. NHS
2 medicines are approved for this disease in Austria:
- Resmetirom (Rezdiffra) – approved in 2025
- Semaglutide (Kayshild, Wegovy Multi FixDose) – approved in 2026
An EU approval is valid in Austria. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Being tested in people
6 open trials in Austria, 271 worldwide. See the trials
- ALN-CIDEB (Phase 3)
- DR10624 Injection (Phase 3)
- Efimosfermin alfa (Phase 3)
- Efruxifermin (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 0 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Cannabis and cannabinoids (CBD, THC) (only single reports in people)
- Amygdalin (laetrile, "vitamin B17") (animal studies only)
- Mistletoe extract (animal studies only)
- Ivermectin (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (39 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Studies liver fat buildup in children with celiac disease
NCT06206616 · ClinicalTrials.gov
Countries: Italy
- Palermo, Italy – Gastroenterological Paediatrics, Children's Hospital "G. Di Cristina"
- Palermo, Italy – General Pediatrics Unit, Children's Hospital "G. Di Cristina"
Ages 1 to 14
Contact the trial teamHeart and Blood Vessel Health in Children With Long-Term Conditions
NCT07086989 · ClinicalTrials.gov
Countries: Hungary
- Budapest, Hungary – Semmelweis University, Pediatric Center
- Budapest, Hungary – Semmelweis University, Department of Surgery, Transplantation and Gastroenterology
- Budapest, Hungary – Semmelweis University, Institute of Preventive Medicine and Public Health
Ages 6 to 25
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamChecking Liver Fat and Eating Habits in Children With Down Syndrome
NCT06888570 · ClinicalTrials.gov
Countries: Spain
- Madrid, Spain – Fundación Jerome Lejeune
Ages 5 to 22
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamComparing two weight loss programs for children with fatty liver disease
NCT05309863 · ClinicalTrials.gov
Countries: Belgium
- De Haan, Belgium – Zeepreventorium
- Ghent, Belgium – University Hospital Gent
- Ghent, Belgium – AZ Jan Palfijn
Ages 8 to 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollows children with fatty liver disease across European centres over time
NCT04190849 · ClinicalTrials.gov
Countries: United Kingdom, Netherlands
- Birmingham, United Kingdom – Birmingham Children's Hospital
- Cambridge, United Kingdom – Addenbrooke's Hospital
- Maastricht, Netherlands – Maastricht UMC
Up to age 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamAmino acid supplements and low sugar diet for fatty liver in children
NCT07459504 · ClinicalTrials.gov
Countries: United States
- Grand Rapids, United States – Corewell Health West
Ages 11 to 17
Contact the trial teamCollects blood and liver samples to study liver diseases
NCT03025074 · ClinicalTrials.gov
Countries: United States
- Buffalo, United States – University at Buffalo, Buffalo General Medical Center
Age 7 and over
Contact the trial teamSoy Milk Compared With Cow's Milk for Fatty Liver Disease in Children
NCT06133101 · ClinicalTrials.gov
Countries: United States
- Cincinnati, United States – Cincinnati Children's Hospital Medical Center
Ages 5 to 16
Contact the trial teamWalking exercise for metabolic syndrome and fatty liver in girls with celiac disease
NCT07832994 · ClinicalTrials.gov
Countries: Egypt
- Giza, Egypt – Cairo University
Ages 13 to 17
Contact the trial teamResmetirom in children and teenagers with metabolic dysfunction-associated steatohepatitis (MASH)
NCT07763015 · ClinicalTrials.gov
Countries: United States
- Indianapolis, United States – Riley Hospital for Children at IU Health
Ages 6 to 17
Contact the trial teamStudying people at higher risk of cancer to find early warning signs
NCT05463796 · ClinicalTrials.gov
Countries: United States
- Boston, United States – Dana-Farber Cancer Institute
No age limit given in the registry
Contact the trial teamStudying how fat builds up in the liver of children with obesity
NCT04634643 · ClinicalTrials.gov
Countries: United States
- New Haven, United States – Yale New Haven Hospital
Ages 12 to 18
Contact the trial teamA blood and ultrasound panel to detect fatty liver disease in children with obesity
NCT07731360 · ClinicalTrials.gov
Countries: Turkey (Türkiye)
- Kayseri, Turkey (Türkiye) – Kayseri City Hospital
Ages 8 to 18
Contact the trial teamLiver Fat and Blood Markers in Teenage Girls With Polycystic Ovary Syndrome and Obesity
NCT07731373 · ClinicalTrials.gov
Countries: Turkey (Türkiye)
- Kayseri, Turkey (Türkiye) – University of Health Sciences, Kayseri City Hospital
Ages 10 to 18
Contact the trial teamFollowing people with hepatitis B and fatty liver disease over time
NCT02863757 · ClinicalTrials.gov
Countries: China
- Hong Kong, China – Humanity and Health GI and Liver Centre
No age limit given in the registry
Contact the trial teamLong-term follow-up of fatty liver disease in Chinese children
NCT03190538 · ClinicalTrials.gov
Countries: China
- Beijing, China – Children's Liver Disease Center, 302 Hospital
Ages 1 to 18
Contact the trial teamStudies guselkumab in psoriatic arthritis patients who also have fatty liver disease
NCT06586281 · ClinicalTrials.gov
Countries: United States
- San Diego, United States – University of California San Diego
No age limit given in the registry
Contact the trial teamScreening for Fatty Liver Disease in People Living With HIV
NCT05330923 · ClinicalTrials.gov
Countries: China
- Beijing, China – Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
No age limit given in the registry
Contact the trial teamFollows pregnant women with liver disease who take Rezdiffra
NCT07541469 · ClinicalTrials.gov
Countries: United States
- West Conshohocken, United States – Madrigal Pharmaceuticals
No age limit given in the registry
Contact the trial teamStudying liver tissue and blood to understand how the liver deteriorates in liver disease
NCT07265544 · ClinicalTrials.gov
Countries: China
- Guangzhou, China – Nan
No age limit given in the registry
Contact the trial teamDASH diet for children with fatty liver disease linked to metabolism
NCT07480811 · ClinicalTrials.gov
Ages 11 to 18
Contact the trial teamTests milk thistle supplement in children with fatty liver disease
NCT06477146 · ClinicalTrials.gov
Countries: United States
- Cleveland, United States – University Hospitals Cleveland Medical Center*
Ages 9 to 22
Contact the trial teamTests empagliflozin against a placebo pill for fatty liver disease in teens
NCT06355310 · ClinicalTrials.gov
Countries: United States
- Chicago, United States – Ann & Robert H. Lurie Children's Hospital of Chicago
Ages 16 to 20
Contact the trial teamUltrasound Methods to Assess Fatty Liver Disease in Children
NCT06706856 · ClinicalTrials.gov
Countries: United States
- La Jolla, United States – University of California San Diego
Ages 9 to 18
Contact the trial teamTests empagliflozin against placebo for fatty liver disease in teenagers
NCT03867487 · ClinicalTrials.gov
Countries: United States
- Chicago, United States – Ann & Robert H. Lurie Children's Hospital of Chicago
Ages 12 to 20
Contact the trial teamCompares two diets for fatty liver in overweight children and teens
NCT06768216 · ClinicalTrials.gov
Countries: India
- New Delhi, India – Institute of Liver & Biliary Sciences
Ages 8 to 18
Contact the trial teamScreening families for food insecurity and referring them to community food support
NCT06661538 · ClinicalTrials.gov
Countries: United States
- La Jolla, United States – UC San Diego
- San Diego, United States – Rady Children's Hospital - San Diego
Age 5 and over
Contact the trial teamStudies how household food insecurity relates to liver fat disease in children
NCT07090083 · ClinicalTrials.gov
Countries: United States
- San Francisco, United States – University of California San Francisco
Ages 6 to 17
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFruit and vegetable vouchers for children with fatty liver and food insecurity
NCT07091539 · ClinicalTrials.gov
Countries: United States
- San Francisco, United States – University of California San Francisco
Ages 6 to 17
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamNew MRI Scans to Assess Fatty Liver Disease Without Needle Biopsy
NCT07149571 · ClinicalTrials.gov
Countries: China
- Wuhan, China – Tongji Hospital
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamLifestyle kit and nutrition counseling for Hispanic children with newly found fatty liver disease
NCT06483711 · ClinicalTrials.gov
Ages 10 to 17
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests low-valine meal replacements in people with overweight or obesity
NCT06883578 · ClinicalTrials.gov
Countries: China
- Shanghai, China – Zhongshan Hospital,Fudan University
Ages 16 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamClassifying fatty liver disease using liver biopsy and prediction tools
NCT06795646 · ClinicalTrials.gov
Countries: China
- Beijing, China – Beijing Friendship Hospital, Capital Medical University
- Hangzhou, China – Hangzhou Normal University Affiliated Hospital
- Shanghai, China – Zhongshan Hospital,Fudan University
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamWalking Program for Fatty Liver in Children With Phenylketonuria
NCT06718842 · ClinicalTrials.gov
Countries: Egypt
- Dokki, Egypt – Cairo University
Ages 9 to 12
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests a mixed fibre supplement for fatty liver disease in children
NCT05480696 · ClinicalTrials.gov
Countries: Canada
- Hamilton, Canada – McMaster University Medical Center
Ages 8 to 17
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests a one-to-one exercise program for obesity-related health problems in teens
NCT06520800 · ClinicalTrials.gov
Ages 13 to 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamWeight-loss surgery for fatty liver disease with scarring in people with obesity
NCT04366999 · ClinicalTrials.gov
Countries: China
- Beijing, China – Beijing Friendship Hospital
Ages 16 to 65
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamEarly warning signs of fatty liver disease in people with hypothyroidism
NCT05813301 · ClinicalTrials.gov
Ages 10 to 85
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamFollowing Chinese people with fatty liver disease to see how it progresses
NCT03282305 · ClinicalTrials.gov
Age 6 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- ReviewStage-Dependent Roles of PANoptosis in MASLD: From Isolated Steatosis to Hepatocellular Carcinoma.Cell Biochem Funct · 2026-11-01
- In peopleBioinformatics and Machine Learning Identify Key Genes in Mitochondrial Homeostasis and Immune Infiltration in Metabolic Dysfunction-Associated Steatotic Liver Disease Progression.Biomed Res Int · 2026-01-01
- KASL Consensus Statement for Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatohepatitis: Focus on Semaglutide.Clin Mol Hepatol · 2026-11-17
- Cardiometabolic index fails to discriminate the histological status of metabolic dysfunction-associated steatotic liver disease patients: A report from biopsy-proven Turkish metabolic dysfunction-associated steatotic liver disease cohort.Hepatol Forum · 2026-10-30
- In peopleClinical Impact of the AISF STEPS-MASH Algorithm: Real-World Application in Tertiary Hepatology Practice.Liver Int · 2026-12-01
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Hepatitis Hilfe Österreich – Plattform Gesunde Leber
Nationwide non-profit patient organisation for all liver diseases, founded in 1999 by patients: counselling, information leaflets and support for patients and relatives.
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (4)
- European Liver Patients' Association (ELPA)
European umbrella of national liver patient groups: liver disease information, HCC patient guide (with ESMO), clinical trial finder and liver cancer advocacy; points patients to member groups.
- Global Liver Institute (GLI)
Global liver health advocacy body with a Liver Cancers Council, patient/caregiver education events and advocate training; not a direct support service.
Phone: +1 800 845 5910
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.